Pradeep Singh
Pulmonary Disease · Seattle, WANPI 1215914999
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $5,100 of the $5,137 with a category attached, or 99.3%. Janssen Research & Development, LLC accounts for 99.3% of it on its own, with 1 other manufacturer making up the rest.
Across 3 payments — averaging $1712.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Janssen Research & Development, LLC$5K
- Vertex$37
Across 11 payments — averaging $97,691 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Vertex$720K
- Gilead$355K
What the payments were for
- Consulting fees$5,10099%
- Food & beverage$371%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Janssen Research & Development, LLC | 2 | $5,100 |
| Vertex | 1 | $37 |
How this compares
$5,137 in reported general payments places this provider in the 80th percentile of 275 pulmonary disease providers in Washington.
Other pulmonary disease in Seattle
- Jed GordenSeattle$236K
- Oneil BainsSeattle$156K
- Ganesh RaghuSeattle$147K
- Jeffrey CarySeattle$106K
- Amy DickeySeattle$71K
- Lawrence HoSeattle$70K
- Christopher GossSeattle$44K
- Reena MehraSeattle$36K
- Rebecca SellSeattle$30K
- Peter LearySeattle$27K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.